Danielle Laperche, Clinical Oncologist at Oncoclínicas&Co and Director of Brazilian Society of Clinical Oncology – SBOC, shared a post on LinkedIn about a paper she co-authored with Breast Cancer Research and Treatment:
“Recent post!
Our multicenter study on the quality of life of Brazilian women with HR+ early breast cancer has just been published in Breast Cancer Research and Treatment. I am very proud to be the author of this work, developed with the contribution of 14 centers in the country, including 774 patients using adjuvant hormone therapy.
We investigated the impact of the type of health coverage – public (SUS) vs. private – on the quality of life of this population.
Women treated in public institutions presented:
- worse pain scores
- More symptoms in the breast and arm
- More nausea and vomiting
- greater financial impact of treatment
Younger age (< 60 years), presence of comorbidities, and ovarian suppression associated with hormone therapy were key factors associated with poorer quality of life.
These results reinforce important inequalities in cancer care in Brazil and point to avenues for policies that prioritize equity and comprehensive support for patients undergoing treatment.”
Title: Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer
Authors: Danielle Laperche‑Santos, Daniele Assad‑Suzuki, Heloisa Resende, Fernanda Cesar Moura, Sulene Cunha Sousa Oliveira, Andrea Kazumi Shimada, Renata Arakelian, Anna Luiza Zapalowski Galvão, Bruno Santos Wance de Souza, Amanda Guimarães Castro Custodio, Monalisa Ceciliana Freitas Moreira de Andrade, Yuri Cardoso Rodrigues Beckedorff Bittencourt, Maria Cristina Figueroa Magalhães, Cristiano de Pádua Souza, Carlos Eduardo Paiva, Poliana Albuquerque Signorini, Daniela Jessica Pereira, Angélica Nogueira‑Rodrigues, Daniela Dornelles Rosa, and Romualdo Barroso‑Sousa
You can read the Full Article in Breast Cancer Research and Treatment.
More posts on Breast Cancer on OncoDaily.